ProMeris

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone
MedicineVeterinaryWithdrawn

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris has been withdrawn at the request of the marketing authorisation holder.

български (BG) (217.29 KB - PDF)

Vizualizare

español (ES) (192.56 KB - PDF)

Vizualizare

čeština (CS) (217.67 KB - PDF)

Vizualizare

dansk (DA) (191.94 KB - PDF)

Vizualizare

Deutsch (DE) (193.36 KB - PDF)

Vizualizare

eesti (ET) (191.37 KB - PDF)

Vizualizare

ελληνικά (EL) (219.08 KB - PDF)

Vizualizare

français (FR) (193.21 KB - PDF)

Vizualizare

italiano (IT) (191.59 KB - PDF)

Vizualizare

latviešu (LV) (213.28 KB - PDF)

Vizualizare

lietuvių (LT) (214.74 KB - PDF)

Vizualizare

magyar (HU) (212.15 KB - PDF)

Vizualizare

Malti (MT) (218.75 KB - PDF)

Vizualizare

Nederlands (NL) (191.68 KB - PDF)

Vizualizare

polski (PL) (216.46 KB - PDF)

Vizualizare

português (PT) (192.4 KB - PDF)

Vizualizare

română (RO) (214.2 KB - PDF)

Vizualizare

slovenčina (SK) (215.86 KB - PDF)

Vizualizare

slovenščina (SL) (208.53 KB - PDF)

Vizualizare

suomi (FI) (191.92 KB - PDF)

Vizualizare

svenska (SV) (191.72 KB - PDF)

Vizualizare

Product information

български (BG) (389.52 KB - PDF)

Vizualizare

español (ES) (328.73 KB - PDF)

Vizualizare

čeština (CS) (374.1 KB - PDF)

Vizualizare

dansk (DA) (330.12 KB - PDF)

Vizualizare

Deutsch (DE) (340.98 KB - PDF)

Vizualizare

eesti (ET) (336.16 KB - PDF)

Vizualizare

ελληνικά (EL) (400.6 KB - PDF)

Vizualizare

français (FR) (342.69 KB - PDF)

Vizualizare

italiano (IT) (310.69 KB - PDF)

Vizualizare

latviešu (LV) (368.86 KB - PDF)

Vizualizare

lietuvių (LT) (376.46 KB - PDF)

Vizualizare

magyar (HU) (368.57 KB - PDF)

Vizualizare

Malti (MT) (376.05 KB - PDF)

Vizualizare

Nederlands (NL) (331.24 KB - PDF)

Vizualizare

polski (PL) (391.6 KB - PDF)

Vizualizare

português (PT) (331.45 KB - PDF)

Vizualizare

română (RO) (368.38 KB - PDF)

Vizualizare

slovenčina (SK) (386.11 KB - PDF)

Vizualizare

slovenščina (SL) (371.43 KB - PDF)

Vizualizare

suomi (FI) (337.57 KB - PDF)

Vizualizare

svenska (SV) (330.13 KB - PDF)

Vizualizare

Íslenska (IS) (332.3 KB - PDF)

Vizualizare

norsk (NO) (340.4 KB - PDF)

Vizualizare
Latest procedure affecting product information:IB/0012
08/07/2015

български (BG) (190.37 KB - PDF)

Vizualizare

español (ES) (144.19 KB - PDF)

Vizualizare

čeština (CS) (184.81 KB - PDF)

Vizualizare

dansk (DA) (144.38 KB - PDF)

Vizualizare

Deutsch (DE) (146.91 KB - PDF)

Vizualizare

eesti (ET) (144.06 KB - PDF)

Vizualizare

ελληνικά (EL) (186.84 KB - PDF)

Vizualizare

français (FR) (141.5 KB - PDF)

Vizualizare

italiano (IT) (144.6 KB - PDF)

Vizualizare

latviešu (LV) (189.21 KB - PDF)

Vizualizare

lietuvių (LT) (179.82 KB - PDF)

Vizualizare

magyar (HU) (175.56 KB - PDF)

Vizualizare

Malti (MT) (198.96 KB - PDF)

Vizualizare

Nederlands (NL) (141.54 KB - PDF)

Vizualizare

polski (PL) (163.63 KB - PDF)

Vizualizare

português (PT) (144.35 KB - PDF)

Vizualizare

română (RO) (142.48 KB - PDF)

Vizualizare

slovenčina (SK) (181.1 KB - PDF)

Vizualizare

slovenščina (SL) (174.66 KB - PDF)

Vizualizare

suomi (FI) (144.95 KB - PDF)

Vizualizare

svenska (SV) (141.76 KB - PDF)

Vizualizare

Íslenska (IS) (141.82 KB - PDF)

Vizualizare

norsk (NO) (141.71 KB - PDF)

Vizualizare

Product details

Name of medicine
ProMeris
Active substance
metaflumizone
International non-proprietary name (INN) or common name
metaflumizone
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AX25

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000107
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
8

Assessment history

This page was last updated on

Share this page